These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 8994512

  • 1. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ, Barnes PJ, Spaethe SM, van Alstyne EL, Mitchell MI, O'Connor BJ.
    Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
    [Abstract] [Full Text] [Related]

  • 2. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z, Timmers MC, van der Veen H, Friedman BS, De Smet M, Depré M, Hilliard D, Bel EH, Sterk PJ.
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [Abstract] [Full Text] [Related]

  • 3. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, Seidenberg BC, Zwinderman AH, Peszek I, Sterk PJ.
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [Abstract] [Full Text] [Related]

  • 4. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.
    Barchuk W, Lambert J, Fuhr R, Jiang JZ, Bertelsen K, Fourie A, Liu X, Silkoff PE, Barnathan ES, Thurmond R.
    Pulm Pharmacol Ther; 2014 Oct; 29(1):15-23. PubMed ID: 25018015
    [Abstract] [Full Text] [Related]

  • 5. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses.
    Wenzel SE, Westcott JY, Larsen GL.
    J Allergy Clin Immunol; 1991 Feb; 87(2):540-8. PubMed ID: 1993813
    [Abstract] [Full Text] [Related]

  • 6. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions.
    Diaz P, Gonzalez MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, Durham SR, Gleich GJ, Kay AB.
    Am Rev Respir Dis; 1989 Jun; 139(6):1383-9. PubMed ID: 2543245
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M, Bruce C, Sjöstrand M, Arvidsson P, Lötvall J.
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [Abstract] [Full Text] [Related]

  • 8. Effect of cyclosporin A on the allergen-induced late asthmatic reaction.
    Sihra BS, Kon OM, Durham SR, Walker S, Barnes NC, Kay AB.
    Thorax; 1997 May; 52(5):447-52. PubMed ID: 9176537
    [Abstract] [Full Text] [Related]

  • 9. Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects.
    Nowak D, Grimminger F, Jörres R, Oldigs M, Rabe KF, Seeger W, Magnussen H.
    Eur Respir J; 1993 Mar; 6(3):405-12. PubMed ID: 8386107
    [Abstract] [Full Text] [Related]

  • 10. The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma.
    Leaker BR, Singh D, Ali FY, Barnes PJ, O'Connor B.
    BMC Pulm Med; 2014 Oct 28; 14():166. PubMed ID: 25351474
    [Abstract] [Full Text] [Related]

  • 11. Effect of histamine and adenosine 5'-monophosphate provocation on sputum neutrophils and related mediators in atopic patients.
    Pohl D, Beier J, Buhl R, Beeh KM.
    Ann Allergy Asthma Immunol; 2005 Aug 28; 95(2):197-203. PubMed ID: 16136771
    [Abstract] [Full Text] [Related]

  • 12. [The changes in cell population and chemical mediators in BALF following local allergen challenge].
    Sunouchi K, Adachi M, Maruyama S, Mizuno M, Tazawa K, Ishihara J, Kobayashi H, Takahashi T, Tsuji A, Maeda M.
    Arerugi; 1991 Jul 28; 40(7):660-8. PubMed ID: 1656921
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL, Watson RM, Wyile G, O'Byrne PM.
    Thorax; 1997 Apr 28; 52(4):348-54. PubMed ID: 9196518
    [Abstract] [Full Text] [Related]

  • 14. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S.
    J Allergy Clin Immunol; 2005 Oct 28; 116(4):761-7. PubMed ID: 16210048
    [Abstract] [Full Text] [Related]

  • 15. Histamine release from bronchoalveolar lavage cells from asthmatic subjects after allergen challenge and relationship to the late asthmatic response.
    Heaney LG, Cross LJ, Ennis M.
    Clin Exp Allergy; 1998 Feb 28; 28(2):196-204. PubMed ID: 9515593
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T, Snyder DW, Pechous PA, Spaethe SM, Roman CR, Fleisch JH.
    J Pharmacol Exp Ther; 1999 Jan 28; 288(1):286-94. PubMed ID: 9862783
    [Abstract] [Full Text] [Related]

  • 17. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM, Beier J, Meyer M, Buhl R, Zahlten R, Wolff G.
    Pulm Pharmacol Ther; 2006 Jan 28; 19(4):233-41. PubMed ID: 16140027
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies.
    Silbaugh SA, Stengel PW, Cockerham SL, Froelich LL, Bendele AM, Spaethe SM, Sofia MJ, Sawyer JS, Jackson WT.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr 28; 361(4):397-404. PubMed ID: 10763854
    [Abstract] [Full Text] [Related]

  • 19. The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man.
    Bel EH, Timmers MC, Dijkman JH, Stahl EG, Sterk PJ.
    J Allergy Clin Immunol; 1990 Jun 28; 85(6):1067-75. PubMed ID: 2191993
    [Abstract] [Full Text] [Related]

  • 20. Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease.
    Waseda K, Miyahara N, Kanehiro A, Ikeda G, Koga H, Fuchimoto Y, Kurimoto E, Tanimoto Y, Kataoka M, Tanimoto M, Gelfand EW.
    Am J Respir Cell Mol Biol; 2011 Oct 28; 45(4):851-7. PubMed ID: 21421908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.